VEGFA and cancer: Specifically in certain cancer cells, KLF4 has been demonstrated to promote hypoxia-induced apoptosis by upregulating the expression of pro-apoptotic genes, and to inhibit hypoxia-induced angiogenesis by downregulating the expression of pro-angiogenic factors such as VEGF (vascular endothelial growth factor) (103).